Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

13 Oct 2015

Abstract excerpt

PURPOSE: We performed a multistage genome-wide association study to identify inherited genetic variants that predict outcome in diffuse large B-cell lymphoma patients treated with immunochemotherapy. METHODS: We conducted a meta-analysis of two genome-wide association study data sets, one from the LNH2003B trial (N = 540), a prospective clinical trial from the Lymphoma Study Association, and the other from the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Chronic Lymphocytic Leukemia Research
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26460308
DOI: 10.1200/jco.2014.60.2573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With ImmunochemotherapyPMID 26460308Read ↗

Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma.Semantic proximity Read ↗

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosisSemantic proximity Read ↗

Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways.Semantic proximity Read ↗

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.Semantic proximity Read ↗

Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trialsSemantic proximity Read ↗

Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphomaSemantic proximity Read ↗

Genetic landscape and prognostic value of IRF4 alterations in Diffuse large B-cell lymphoma patientsSemantic proximity Read ↗

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.Semantic proximity Read ↗

Identification of genomic biomarkers of disease progression and survival in primary CNS lymphomaSemantic proximity Read ↗

Molecularly Adapted Antitumor Therapy for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Two-Year Follow-Up ResultsSemantic proximity Read ↗

Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.